According to Dentsply Sirona
's latest financial reports the company has a price-to-book ratio of 1.94.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 2.29 | 27.52% |
2022-12-31 | 1.80 | -26.45% |
2021-12-31 | 2.44 | 5.25% |
2020-12-31 | 2.32 | -5.66% |
2019-12-31 | 2.46 | 52.05% |
2018-12-31 | 1.62 | -29.14% |
2017-12-31 | 2.28 | 39.08% |
2016-12-31 | 1.64 | -54.99% |
2015-12-31 | 3.64 | 12.75% |
2014-12-31 | 3.23 | 20.78% |
2013-12-31 | 2.68 | 6.8% |
2012-12-31 | 2.51 | -4.68% |
2011-12-31 | 2.63 | 3.62% |
2010-12-31 | 2.54 | -6.43% |
2009-12-31 | 2.71 | 2.33% |
2008-12-31 | 2.65 | -40.89% |
2007-12-31 | 4.48 | 26.03% |
2006-12-31 | 3.56 | 4.68% |
2005-12-31 | 3.40 | 8.35% |
2004-12-31 | 3.14 | -1.74% |
2003-12-31 | 3.19 | -8.4% |
2002-12-31 | 3.48 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Danaher DHR | 3.40 | 75.68% | ๐บ๐ธ USA |
3M MMM | 10.4 | 438.01% | ๐บ๐ธ USA |
Align Technology
ALGN | 6.62 | 242.03% | ๐บ๐ธ USA |
Integra LifeSciences IART | 1.40 | -27.44% | ๐บ๐ธ USA |
Biolase
BIOL | 0.8139 | -57.96% | ๐บ๐ธ USA |